A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279...

Area of Science:

• Cardiology
• Pharmacology

Background:

• Aspirin is crucial for managing coronary artery disease (CAD).
• Patient non-compliance or discontinuation of aspirin therapy is a clinical concern.
• Understanding the risks of aspirin withdrawal in CAD is essential for patient outcomes.

Purpose of the Study:

• To systematically review the hazards associated with aspirin withdrawal or non-compliance in patients with or at risk for CAD.
• To quantify the increased risk of adverse cardiac events due to aspirin discontinuation.

Main Methods:

• Systematic search of electronic databases (updated January 2006).
• Inclusion of six studies involving 50,279 patients.
• Pooled analysis using random-effect methods to calculate odds ratios (OR).

Main Results:

• Aspirin non-adherence or withdrawal was linked to a three-fold higher risk of major adverse cardiac events (OR=3.14).
• The risk of adverse events was dramatically amplified in patients with intracoronary stents following antiplatelet treatment discontinuation (OR=89.78).

Conclusions:

• Aspirin non-compliance or withdrawal has serious prognostic implications for patients with moderate-to-high risk of CAD.
• Discontinuation of aspirin should only be considered when bleeding risks substantially outweigh atherothrombotic event risks.